Three gene therapy pioneers just won the Breakthrough Prize. This is their story
Ryan Cross / endpoints - A trio of scientists behind the first gene therapy approved in the United States have been awarded a Breakthrough Prize in Life Sciences. It’s arguably one of the most prominent recognitions yet for the field ...
AI Summary: Three gene‑therapy researchers received the Breakthrough Prize in recognition of foundational work that enabled the first CRISPR-based sickle cell therapy. The award highlights decades of basic and translational research that turned genome editing from lab curiosity into a tangible clinical remedy, with winners sharing a multimillion‑dollar prize and public acclaim.
Related Stories
Analysis finds anti-amyloid Alzheimer's drugs lack meaningful benefit / 2 months
The peptide problem: Hype outruns evidence, researchers caution / 2 months
Mid‑stage Parkinson trial failure halts drug development plans / 7 wks
FDA clears AstraZeneca’s new blood-pressure drug baxdrostat / 7 wks
Antiviral ensitrelvir dramatically cuts household COVID transmission risk / 1 month
First‑in‑human CRISPR/Cas12a sickle cell therapy treated; gene editing shows promise / 3 months
Denali drug receives accelerated approval for rare CNS indication / 3 months
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Infant Health, Mergers and Acquisitions, Health IT, Pancreatic Cancer and look for the RSS link.
StackHealth Time Machine